REPLIGEN CORP (RGEN)
NASDAQ • Healthcare
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About REPLIGEN CORP
Repligen Corporation develops and sells bioprocessing equipment, materials, and integrated systems for biologic drug manufacturing and related laboratory work. Listed on the NASDAQ as RGEN, the healthcare company operates in the medical instruments and supplies business and generated $738.3 million of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
REPLIGEN CORP's Technical Indicators Summary
RGEN exhibits a clear bullish profile: the stock trades well above its short-, medium- and long-term moving averages, MACD and momentum readings are strongly positive, and OBV confirms buying interest. Trend strength is pronounced with ADX comfortably above 40, and while ATR indicates moderate absolute volatility it is proportionate to price. Classic pivot levels are near recent trade but do not outweigh the broad trend confirmation from moving averages and momentum. Technical takeaway: Strong Buy.
| Indicator | Value |
|---|---|
RSI (14) | 66.70 |
Stochastic %K (14, 3, 3) | 94.13 |
CCI (20) | 81.61 |
WPR (14) | -11.13 |
Momentum (10) | 16.37 |
MFI | 82.39 |
MACD Level (12, 26) | 7.69 |
Bollinger Bands | $126.63 - $178.76 |
ATR (14) | $6.52 (3.93%) |
ADX (14) | 42.87 |
OBV | 12,971,340 |
Classic Pivot Point | $167.72 |
Fibonacci Pivot Point | $167.72 |
Simple Moving Averages | $131.32 - $164.51(5 indicators) |
Exponential Moving Averages | $139.10 - $162.86(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
RGEN recorded a minor loss during the previous session, ticking down to 166.15. RGEN could extend gains as Q2 guidance is raised, shifting the bull case higher.
Trading Volume
Below 10d avg (853.0K)
452.6K
vs S&P 500 Today
Underperforming Market
-1.02%
52-Week Position
Upper range
87.1%
Updated: August 19, 2026 at 12:20 UTC
Quote Summary
RGEN Headlines
Healthcare stocks fall after weak US jobs data
March 6, 2026